Radar snapshot

22
Ingredients tracked
3
Fringe signals
5
Segments

Highest velocity signals this month

Charcoal toothpaste — ADA and BDA negative evidence statements active. Enamel abrasivity risk. No ADA seal. Exit or reposition urgently.
Hydroxyapatite — Evidence-equivalent to fluoride for remineralisation in growing RCT literature. EU allows HA claims; FDA does not yet. US claim gap is the opportunity.
Oral microbiome probiotics — BLIS K12 and BLIS M18 building clinical backing for caries prevention and periodontal support. First-mover category still forming.
PAP whitening — Phthalimido-peroxy-caproic acid validated as peroxide-free whitening agent. EU-compliant, enamel-safe. Growing adoption by premium dental brands.

Current alerts

RedCharcoal oral care — ADA/BDA negative evidence, enamel risk
RedHigh-concentration peroxide whitening — EU restriction at >0.1%
AmberHydroxyapatite vs fluoride — EU allows claims, FDA does not yet
AmberUS fluoride OTC monograph review — EPA MCL reassessment ongoing
SignalOral microbiome — BLIS K12/M18 gaining clinical credibility

This edition

22 oral health ingredients and technologies seeded across five segments
2 red alerts — charcoal oral care evidence, EU peroxide restriction
5 white space opportunities mapped — oral microbiome leads

"Oral health is the most evidence-driven segment in consumer health — the brands that build clinical credibility now will define the category for the next decade."

About Brendan Walsh →